By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


CV Therapeutics, Inc. 

3172 Porter Drive

Palo Alto  California  94304  U.S.A.
Phone: 650-384-8500 Fax: 650-858-0390



Genta Incorporated 

Company News
Gilead Sciences, Inc. (GILD) Successfully Completes Tender Offer for Shares of CV Therapeutics, Inc. (CVTX) With Over 88 Percent of Shares Tendered 4/15/2009 9:15:12 AM
CV Therapeutics, Inc. (CVTX)'s Board of Directors Recommends Stockholders Accept Gilead Sciences Ltd. (GILD)'s $20.00 per Share Cash Tender Offer 3/19/2009 11:06:37 AM
CV Therapeutics, Inc. (CVTX) Announces Presentations at the American College of Cardiology 58th Annual Scientific Session 3/17/2009 12:50:27 PM
Astellas Pharma Inc. (JOBS) Pulls Plug on $1 Billion CV Therapeutics, Inc. (CVTX) (JOBS) Bid 3/16/2009 7:33:14 AM
CV Therapeutics, Inc. (CVTX)'s (JOBS) Board of Directors Rejects Astellas Pharma Inc.'s (JOBS) Tender Offer 3/13/2009 7:30:50 AM
Gilead Sciences, Inc. (GILD) Buying CV Therapeutics, Inc. (CVTX) for $1.4 Billion 3/12/2009 7:25:47 AM
Astellas Pharma US, Inc. to Nominate Two Directors and Submit Proposal to Remove Remaining Four Directors of CV Therapeutics, Inc. (CVTX) 3/6/2009 8:43:23 AM
CV Therapeutics, Inc. (CVTX) Reports Phase 1 Data Showing Proof of Concept for CVT-3619, a Novel Potential Treatment for Cardiometabolic Diseases 3/5/2009 11:01:21 AM
CV Therapeutics, Inc. (CVTX)'s Ranexa(R) Now Available in United Kingdom and Germany 3/3/2009 11:41:14 AM
CV Therapeutics, Inc. (CVTX) Advises Stockholders to Take No Action at This Time in Response to Astellas Pharma Inc.' Tender Offer 3/2/2009 8:59:43 AM